Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004067543 | SCV003754774 | uncertain significance | not specified | 2021-07-06 | criteria provided, single submitter | clinical testing | The c.395G>A (p.S132N) alteration is located in exon 3 (coding exon 3) of the MMP26 gene. This alteration results from a G to A substitution at nucleotide position 395, causing the serine (S) at amino acid position 132 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Caryl and Israel Englander Institute for Precision Medicine, |
RCV002463916 | SCV002758687 | uncertain significance | Myoepithelial tumor | 2022-11-01 | no assertion criteria provided | research |